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IPTRODUCTIOid 
The standard method of estimating the rate of glomerular filtration 
(G.F.R.) in man has been by the renal clearance of inulin since it was 
demonstrated. that this plant polysaccharide is neither secreted nor 
reabsorbed by the renal tubules. The criteria which must be satisfied 
by a substance for its renal clearance to cive a valid measure of glom - 
erular filtration rate have been discussed in detail by Smith (1951). 
Chemical methods for the determination of inulin in plasma and urine 
have been rather unsatisfactory (Smith 1951) and a variety of substances 
have been studied in an attempt to find a substitute for inulin. The 
endogenous creatinine clearance is widely used for clinical purposes but 
the creatinine/inulin clearance ratio exceeds unity in many human 
subjects indicating a variable deree of tubular secretion of creatinine 
(Smith 1 951 , Berlune et al 1 964) and this clearance is not a reliable 
measure of glomerular filtration in man. 
Recently a number of compounds labelled with radioisótopes have 
been studied and found to have clearances similar to'that of inulin. 
Al.lyl inulin labelled with 1251 has a clearance virtually identical to 
that of inulin in tae dog (Concannon et al 1961 +) but is not rea¡._.ly 
available and is difficult to sterilise. Radioactive 57Co- labelled 
cyanocobalamin gives a satisfactory measure of G.F.R. if only the free 
vitamin in the plasma is measured (Nelp et al 1964, Cutler and Glatte 1965). 
However, even after a large loading dose of unlabelled cyanocobalamin, 
plasma protein binding, of the labelled compound occurs and is variable 
in extent, nor is it easy to determine the proportion. of the labelled/ 
- 2 - 
labelled vitamin which is plasma bound in vivo (Skins and Sgherzi 1964, 
Donaldson and Doig unpublished observations). The most convenient 
inulin substitutes so far available are .the radiographic contrast media 
sodium diatrizoate ( Hypaque) and meglumin diatrizoate (Renografin) 
labelled with 1311 Or 251. In man Hypaque appears to fulfil many of 
Smith's criteria, it is not significantly bound to plasma proteins 
(Lasser et al 1962) nor does it readily penetrate red blood cells 
(Denneberg et al 1961), its renal excretion is complete ano its extra- 
renal excretion negligible (Denneberg 1965). Hypac,ue and Renografin 
have been shown by various authors to have clearances very similar to 
the simultaneous inulin or thiosulphate clearance in man and the 
literature on these compounds has been well reviewed by Denneberg (1965). 
However some authors have not found the Hypaque and inulin or thiosul- 
phate clearances to be identical (Bianchi and Zampieri 1961, Woodruff 
and Malvin 1560, Stokes et al 1 ;62, Denneberg 1565 and while some 
comparisons were carried out during continuous infusion of inulin and 
Hypaque (Burbank et al 1963), others were made on the basis of a single 
injection of Hypaque (Bianchi and Zampieri 1961). The latter are difficult 
to interpret physiologically; the difficulties inherent in all "single 
injection" clearances have been discussed by Smith (1 951) and Robson et 
al (1949) . 
It has been variously suggested that Hypaque is neither reabsorbed 
nor secreted by the renal tubules in man (Burbank et al 1963), nor in 
the dog Woodruff and Malvin 1960), that it is reabsorbed in man (Bianchi/ 
_3 
bianchi and Zampieri 1961) and in dog (Stokes et al 1962) and that it is 
both secreted and reabsorbed in man (Denneberg 1965). 
Morris et al (1965) found that the clearance of 1311 Renografin 
did not alter when the plasma level was raised by large doses of inactive 
Renografin, suggesting that this compound is not handled by the tubules. 
However they studied only two subjects in this way. Hypaque would be 
expected to behave in the renal tubules in the same way as Renografin 
as it is the diatrizoate ion which is estimated in both cases. However 
Denneberg (1965)'found that the Hypaque /inulin clearance ratio fell, on 
average, after the administration of the tubular blocking agent probenecid 
and concluded that Hypaque is secreted and perhaps also reabsorbed by the 
renal tubules in man. 
Because of this confusion in the literature about tubular handling 
of Hypaque in man, the studies described in this paper were carried out 
in an attempt to resolve the Question of whether or not radioactive 
labelled Hypaque is handled by the renal tubules and to investigate its 
clearance as a measure of the rate of glomerular filtration in human 
subjects. 
P<ïATERLiL AND IP,THODS 
Two groups of studies were carried out. 
i . PRï,LIiIN RY OBSERVATIONS WITH LABELLED ff PÀUE ONLY. 
total of 91 simultaneous clearances of inulin and labelled Hypauue 
were carried out during continuous infusion of the test substances, 65 
using 131I Hypaque and 26 with 1 5I Hypaque. Of the total, 46 were 
clearances on single kidneys carried out during divided renal function 
studies in hypertensive patients while the remaining 45 were bladder 
clearances in patients with a variety of'renal and non -renal disorders. 
The bladder clearances were carried out as described below in section 2; 
the single kidney clearances were carried out similarly, using urine 
collected from ureteric catheters by a technique similar to that of 
Stamey (1961). The isotope count rates were determined as described 
below. Inulin was measured in this series by the ;,ethod. of Hyrovsky (1956). 
Plasma proteins were precipitated with cadmium sulphate and sodium 
hydroxide to give a final dilution in the filtrate of 1:15. Urines 
were precipitated only if protein was present and were appropriately 
diluted. Five inulin standards were used and all estimations were carried 
out in triplicate. Clearances were calculated as described below. 
2. STUDIES WITH UNLABELLED FIYPAQUE . 
PROCEDURE:- the subjects were six adult patients, five male and 
one female. The procedure was carried out in the morning with the 
subject fasting overnight. Subjects lay supine on a comfortable mattress/ 
5 
mattress in a warm room, urine was collected by voluntary voiding 
throughout and with the subject standing or sitting up during bladder 
emptying. Plastic catheters were inserted percutaneously into forearm 
veins, two in one arm and one in the other. Through one catheter a 
15' solution of mannitol was infused at approximately 10 ml. /min. 
throughout the procedure to maintain an osmotic diuresis. One of the 
remaining catheters was used for the continuous infusion of a Hypaque/ 
inulin mixture as described below. The other was used for blood sampling. 
Blood was always taken from the arm opposite to that receiving the 
Hypaque /inulin infusion, it was withdrawn into heparinised syringes and 
then expelled into plastic tubes containing a drop of heparin in which 
it was immediately centrifuged and the plasma separated. 
Six clearances were carried out in each subject, three with tracer 
doses of 1251 labelled Hypaque only and a further three after a single 
dose of unlabelled Hypaque, in accordance with a strict programme which 
was identical for each subject. 
Previous experience had shown that the urine passed at the beginning 
of the procedure was highly concentrated and had a relatively high 
inulin -like activity. A blank clearance was therefore carried out under 
mannitol diuresis to obtain urine of a concentration comparable to that 
obtained during the inulin and Hypaque clearances. This involved a timed 
urine collection over 20 minutes during mannitol diuresis with a blood 
sample which provided the plasma inulin blank taken at the mid time/ 
6 
time. Under these conditions the urine inulin blank was always less 
than 0.54 of the average urine level during the clearances. 
Following the blank clearance priming doses of inulin and 1251 
Hypaque were injected and followed by a continuous infusion containing 
inulin and 
125 
1 Hypaque administered at a constant rate of 1 ml./min. 
by an infusion pump. The priming doses were calculated on the basis of 
body weight to give a plasma inulin level of about 250 pug. jml. and a 
total count for plasma 1?51 activity of not less than 10,000 counts 
above background under the counting conditions described below. The 
concentration of the sustaining infusion was calculated on the basis of 
expected G.F.R. to maintain these levels when infused at 1 ml. /min. The 
total dose of radioactive material varied from 5 to 25 iuc of 1251. «fter 
15 to 20 minutes for equilibration the bladder was emptied and the urine 
discarded and the first clearance period was started. The duration of 
trre clearance periods depended upon the rate of urine flow but was 
usually b to 10 minutes between urine collections with blood withdrawn 
at the mid clearance time. Three consecutive clearances were carried 
out in this way. Immediately following the urine collection for the third 
clearance 40 mis. of a 45% solution of unlabelled Hypaque (Bayer Products) 
was injected over a period of one minute into the mannitol infusion 
catheter. ho adverse reactions to the injection occurred in any subject. 
The consecutive clearances continued without interruption until another 
three had been carried out marring a total of six when the procedure was 
stopped and the catheters removed. 
The/ 
The urine volumes for each clearance were measured immediately and 
were always large enough to allow measurements to the nearest 1 ml. 
using a measuring cylinder. Rates of urine flow were obtained by 
dividing these volumes by the clearance times. 
AÌ,ALYTICîL METHODS 
1. Inulin. Inulin concentration in plasma and urine was measured 
using a modification of the resorcinol method adapted for use on the 
Auto- Analyser (Technicon) by the Department of Biochemistry, University 
of Edinburgh. Protein free filtrates were prepared by the zinc sulphate 
precipitation method. of SomoWri (1930) from 2 ml. samples of plasma to 
give a final dilution of 1:15 for all samples. The urine in this series 
was found to be virtually protein free and urine samples were simply 
diluted 1:50 or 1:100 except for the blank (0) which was not diluted. 
Inulin standards containing; 10, 2U and 30 dug'. jml. of inulin were used. 
The following method of running the Samples and of calculation of the 
unknown concentrations was developed by Professor R. B.. Fisher. The 
samples were run on the auto Analyser according to a lattice in which 
corresponding plasma and urine samples were adjacent (Table 1). This 
lattice was designed to minimise the effects of base line drift of the 
instrument and to provide frequent estimations of the standards. As 
shown in Table 1 the samples were run in groups in forward then in 
reverse order bracketed between sets of standards run first in ascending 























































































































































































































































samples was then run with the order of the groups and the order of 
samples within each group reversed. The percentage optical transmission 
at )+80 rnp. was recorded on a strip chart and the values were read from 
this to three significant figures. The inulin concentrations were 
calculated by a digital computer for each group of samples separately. 
The principles of this calculation are as follows:- the percentage 
transmissions were converted to ootical densities and the best line 
relating concentration to optical density was calculated from the three 
pairs of standard determinations which bracketed each group of uncnoins. 
From the coefficients of this line the best esti_uates of the unknown 
concentrations were calculated giving a pair of estimates for, each 
sample in each group. The mean of each of these pairs was treated as 
a single observation of that sample. Thus from each group one mean 
value was obtained for each of two adjacent pairs of urine and plasma 
samples. As the whole procedure was run in duplicate but in reverse 
order the eventual result was two mean values for each plasma and urine 
filtrate. The average of these two mean values was used as the best 
estimate of concentration in all further calculations. (Under these 
conditions the deviation of the two mean values from their average did 
not exceed 1%). Mu1ti)licat__on by the appropriate dilution factor and 
subtraction of the appropriate blank gave the inulin concentration in 
ju,J. /ml. of plasata or urine. Studies of inulin recovery from human 
serum over the range of 100 to 400/1.6./M1. of added inulin gave a mean 
recovers, of 99.54 
± 
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was calculated from the urine /plasma concentration ratios thus: - 
u 
sy /P Hy 
C Hy/`C In - 
U In /P In_ 
which avoids rounding off errors due to multiplying then dividing by 
the rate of urine flow. 
RESULTS 
1. Preliminary observations. 
The values of the clearances and their ratio in the preliminary 
series are not tabulated in detail. Figure 1 shows the linear regression 
125 
of I Hypaque clearance against the simultaneous clearance of inulin 
calculated by the method of least squares and Figure 2 shows the corres- 
ponding line for 
131 
1 Hypaque and inulin. All statistical calculations 
were performed by standard techniques as described by Mather (1551) and 
in each case the values of the clearances from which the line was calcul- 
ated are plotted. The mean val-u.e .of the ratio Hypaque clearance /inulin 
clearance is shown together with the range of the ratio. However these 
mean values must be interpreted with caution, as discussed below. 
The equation of the regression line for 
125 
Hypaque on inulin is 
C _Hy = 0.95(C In) + 7.35 (Fig.1) . The standard error (S.E.) of the slope 
is - 0.0256. Testing the difference of the slope from unity gives a 
value of i (for 24 degrees of freedom) of 2.072 for which the corres- 










































































































































































































































































































































































































the difference of the intercept from zero is 1.226 giving p between 
0.30 and 0.20. The correlation coefficient (r) is 0.922 for which 
p<0.001. The corresponding, equation for 131 I üypaque (Fig. 2) is 
C By = 0.93 (C In) # 9.67 with standard errors of slope ?nd intercept 
of -F 0.0317 and -F 2.2388 respectively. Testing the difference of the 
slope from unity and the intercept from zero as before, the values of 
t (for 63 degrees of freedom) are 2.308 for the slope and 3.768 for 
the intercept, giving corresponding values of p between 0.02 and 0.01 
for the difference of the' slope from unity and p<0.001 for the difference 
of the intercept from zero. The correlation coefficient (r) is 0.965 
with p<0.001. The mean valué of the ratio was 1.11 for both isotope 
labels. These mean values of the ratio are derived from groups of 
patients in each of whom a number of determinations of the ratio was 
made and the Question arises whether the groups of observations for 
either isotope can be considered as a single population with a mean of 
1.11 to which a variance can be assigned. The hypothesis that all of 
the observations for each isotope have a common variance was tested by 
Bartlett's test for each group (Bartlett 1937). For the 1251 data a 
value for the heterogeneity X of 59.72 for 6 degrees of freedom was 
obtained with a corresponding value of p(0.0005. For the 131I data the 
results were X. = 210.97 for 15 degrees of freedom giving p<0.0005. 
Thus in each case the hetetogeneity 
z 
is highly significant and neither 
group of data can be considered as a single population nor can a variance 
be assigned to the mean of either group. The significance of the differ- 
ence of the means from unity cannot therefore be assessed. The implications/ 
- 12 - 
implications of these findings are discussed more fully below. 
2. Studies with tracer and unlabelled 1z)1 Hypaque. 
The results of these studies are presented in full. In each table 
"Low" refers to the first three clearances which were carried out with 
tracer Hypaque only and "High" refers to the last three clearances 
after injection of unlabelled Hypaque. Table 2 shows the rate of urine 
flow in each clearance period. In most patients there is no abrupt 
change in urine flow from period to period but in patients 2 and 6 
bladder emptying was probably incomplete on at least oilé occasion, 
resulting in sudden changes in the apparent urine flow. Such errors in 
urine flow affect the values of the clearances but not the ratio of 
Hypaque clearance / inulin clearance. The plasna and urine inulin 
concentrations are shown in Table 3 and the total counts above background 
of 1251, indicating relative concentration of labelled Hypaque, in Table 4. 
Count rates between patients are not comparable as the counts were not 
referred to a standard; within each patient all counts are expressed as 
totals for a common counting period (usually 1,000 secs.). The plasma 
levels of Hypaque and inulin show slight fluctuation between consecutive 
clearance periods but this is only approximately 6.5% at its greatest 
during the first three clearance periods and the levels tend to become 
steadier in the latter part of the experiment. The clearances of inulin 
and Hypaque and the ratio Hypaque clearance/inulin clearance are shown 
for each period in Table 5 a, b and c. There are abrupt changes in both 























































































































































































































































































































































































































































































































































































































































































































































































































































































































2 3 4 
a) Inulin Clearance ml /min. 
HIGH 
5 6 
1 125.5 111.8 105.6 120.5 104.9 110.1 
2 85.2 78.1 92.8 81.8 51.3 87.2 
3 84.4 89.3 87.8 92.8 92.1 91.0 
4 140.7 120.8 147.5 118.6 127.7 114.9 
5 83.6 70.8 72.1 76.6 68.2 72.5 
6 121.3 53.4 128.0 73.1 80.6 65.8 
b) Hypaque Clearance ml /min. 
1 126.6 106.6 110.7 109.9 101.9 104.9 
2 95.5 90.5 103.1 90.4 53.6 89.0 
3 91.3 95.7 98.9 98.3 90.5 92.2 
4 131.9 118.9 147.9 115.5 118.9 107.8 
5 87.5 74.1 77.2 86.7 70.2 64.0 
6 120.5 57.4 143.9 83.6 86.1 68.9 
c) Ratio C Hypaque Í C Inulin 
1 1.01 0.95 1.05 0.91 0.97 0.95 
2 1.12 1.16 1.11 1.11 1.05 1.02 
3 1.08 1.07 1.13 1.06 0.98 1.01 
4 0.94 0.98 1.00 0.97 0.93 0.94 
5 1.05 1.05 1.07 1.13 1.03 0.88 
6 0.99 1.07 1.12 1.14 1.07 1.05 
LOW - clearances with tracer 125I Hypaque only 
HIGH - clearances after injection of 18 gm. of unlabelled Hypaque 
- 13 - 
correspond to the bladder emptying errors noted above. However Table 5(c) 
shows that there were no changes of corresponding magnitude in the ratio 
at these times. It is also apparent that the ratio remains close to 
unity at both "Low" and "High" Hypaque levels, 
The effect of the injection of unlabelled Hypaque on the clearances 
of inulin and Hypaque and on the ratio Hypaque clearance/inulin clearance 
was studied by subjecting the data from this series of experiments to an 
analysis of variance. The calculations were carried out by standard 
methods similar to those described by Iviather (1 951) and the results of 
the analysis are shown in Tables 6, 7 and 8. The main findin;s are a 
significant fall in the mean value of the ratio between "Low' and "High" 
accompanied by significant falls in the mean clearances of both- inulin 
and Hypaque. 
DISCUSSION 
Analysis of the results of the preliminary studies with tracer doses . 
of labelled Hypaque showed that there was an excellent linear correlation 
between the simultaneous clearances of Hypaque labelled with either 1 5I 
or 131I and inulin (Figs.1 and 2). If Hypaque were excreted only by 
glomerular filtration the regression for Hypaque clearance on inulin 
clearance would be expected to differ from a line of slope unity and 
intercept zero only by the errors inherent in the methods of making the/ 
the observations. The slope of the regression for Hypaque labelled with 
either isotope is close to unity ((0.95 for 1 5T and 0.93 for 131 I) though 
in both cases the difference from unity is suggestively large and is 
significant at the 5 but not the 1jß level of probability. The intercept 
in each case exceeds ero; the value of 7.35 for 
1251 
is not significant 
131 
but that of 9.67 for T is statistically significant. The overall 
result is that the Hypaque clearance tends to be greater than the simul- 
taneous inulin clearance suggesting that Hyua.uue may be secreted by the 
tubules to a small extent. As the slopes of both regressions are close 
to unity the ratio of Hypaque clearance to inulin clearance ( "the ratio") 
should provide an adequate measure of the behaviour of the Hypaque 
clearance relative to that of, inulin with the additional advantage of 
avoiding errors due to inaccuracies in measurement of urine flow. The 
mean value of 1 .1 1 for the ratio for both isotope labels confirms the 
tendency to a higher Hypaque clearance than is likely if Hypa,que were 
excreted by filtration alone. Unfortunately these preliminary experi- 
ments were not well designed for statistical analysis and as has been 
shown above, the data cannot supply a valid estimate of the variance of 
the mean ratio for either label and thus it is impossible to test the 
significance of the difference of the mean ratio from unity. In summary 
the results of the preliminary observations show that the Hypaque clearance 
is, on average, somewhat higher than the inulin clearance and sugest 
that.a small proportion of the excreted Hypaque may be secreted by the 
renal tubules. _4 further series of experiments was designed to test the 
hypothesis that there is some tubular secretion of Hypaque by studying/ 
- 15 - 
studying the effect on the-clearance ratio of a large dose of unlabelled 
Hypaque. If a mechanism for tubular secretion of Hypaque exists it 
should be possible to saturate this by raising the plasma Hypaque level 
sufficiently and the Hypaque clearance should then approach that of 
inulin with a consequent fall in the ratio towards unity. The 
1251 
label 
was used as this had proved more convenient for stora ̂e than 1311 and 
gave a smallet radiation dose to the subject. The Auto Analyser method 
for inulin is. considerably more precise than the manual method used for 
the earlier studies. However, it is apparent that the variability. between 
subjects is considerable and as it is not practicable to carry out more 
than ahout six consecutive clearances on any one subject, a considerable 
variance between subjects cannot be avoided. The technique of Analysis 
of Variance allows the desired effect (that of added Hypaque) to be 
isolated from the effects on the ratio of variance between subjects and 
any effect due to the order in which clearances are performed. The 
experiments were designed to be analysed in this way and each of the six 
subjects was studied in identical fashion before- and after an intravenous 
dose of approximately 18 gm. of unlabelled Hypaque. A single dose was 
used as it is not essential. to know the precise level of unlabelled 
Hypaque and in any case this would be difficult to Measure chemically 
with the precision necessary to allow clearances of unlabelled . ipaque 
to be determined. The dose of 18 gm. is sufficient to raise the total 
plasma level of Hypaque several thousand fold. 
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been described but the analysis of variance performed on them will now 
be presented in more detail. The total of 36 clearance periods provides 
35 degrees of freedom for estimation of the total variance. These are 
partitioned as follows:- 5 degrees of freedom for the variance between 
the six subjects, 2 for variance due to order within the three "Low" 
plasma level clearances and 2 for the corresponding "High" clearances 
making 4 for the =within treatment" variance; there is 1 degree of 
freedom for comparison between the treatments (Low and High) accounting 
in all for 10 degrees of freedom and leaving 25 for the interaction, 
subjects treatment x order, which supplies the estimate of error. 
The total sure of squares is partitioned in corresponding fashion. 
Table 6 shows the results for the ratio and Table 7 and Table 8 the 
results of performing the same analysis on the actual clearances of 
inulin and Hypaque respectively. The effect of Unlabelled Hypaque on the 
ratio is the most important result. ieferrinr to Table 6 it is clear 
that all the effects are significant at 1% or less, that is the variance 
between subjects, that due to order, and the effect of Hypaque are all 
significant compared to the error variance. The mean value of the ratio 
before added Hypaque is 1.05 while after unlabelled Hypaque it is 1.01 and 
the change is significant at 1%. Although the data when analysed in 
this way allows the conclusion that a significant change in the ratio 
has occurred after Hypaque there is no such satisfactory means of 
testing the difference of the ratio from unity. To perform such a test 
the only estimate available of the variance of the lower ratio (expressed 
here as percentage, 101%) is that derived from the total mean square/ 
- 17 - 
square which includes all the sources of variation. The variance derived 
in this way of the ratio after Hypaque is ± 1.2 making it clear that a 
ratio of 101% cannot be distinguished from a ratio of 1005 (correspondin,_: 
to unity) on the basis of the data available. This being so, as it has 
been clearly established that there is s significant difference in the 
ratio before and after Hypaque, it is reasonable to conclude that the 
effect of adding unlabelled Hypaque is to significantly depress the 
ratio to a value indistinguishable from unity. This result agrees with 
the prediction on the hypothesis that when only tracer doses of Hypaque 
are used, a small proportion is secreted by the tubules and that the 
tubular secretory mechanism can be saturated by elevating the plasma 
Hypaque level. The hypothesis of tubular secretion provides the simplest 
and most probable explanation of the results. Mean values of the ratio 
of less than unity were not found in either of the groups of studies and 
the present data does not support the suggestion that reabsorption of 
Hypaque occurs in man. 
It is of interest that a similar analysis of the actual clearances 
(Tables 7 and 8) shows significant falls in both inulin and Hypaque 
clearances after administration of Hypaque. As it is hardly possible 
that Hypaque could depress the inulin clearance while the rate of 
glomerular filtration remained unchanged the G.F.R. must have fallen, 
on average, during the latter half of the study. This is probably an 
effect unrelated to the administration of Hypaque but may be related to 
loss of sodium and water due to the continuous osmotic diuresis maintained/ 
- 18 - 
maintained throughout the experiments. 
The small amount of tubular secretion of Hypaque,when tracer levels 
are used is unlikely to be of significance in most situations where a 
measure of G.E.R. is required in man, as, on average, it amounts to only 
about 5% of the simultaneous inulin clearance and in any event inulin 
clearances are difficult to determine with errors less than 5°,1% Labelled 
Hypaque is easily estimated in plasma and urine, no protein precipitation 
is required and the technique is much less exacting than that required 
for inulin estimation, and,if necessary, there should he no difficulty 
in reducing the effect of tubular secretion by adding unlabelled Hypaque 
to the infusion. It would appear that for most purposes the inulin 
clearance in man.could be replaced by tie clearance of radioactive labelled 
Hypaque without any loss and with a considerable saving in laboratory time. 
- 19 - 
Sti?1':i.iARY 
1. Studies in man of the simultaneous renal clearances Of Hyua.oue 
125 131 
labelled with or I and inuli:d over a total of 91 cle_ra ce 
perm is indicated that there was a linear correlation between the 
clearances and also that the Hypaque clearances tended to be hi:er than 
that of inulin suggestin° that there was some tubular secretion of Hv3aqu=. 
2'. The effect of unlabelled Hypaque on the ratio Hypaque clearance/ 
inulin clearance was studied in 6 subjects. 
3. The mean ratio with tracer Hypaque only was 1.05 but after 
unlabelled Hypaque it fell to 1.01 and this change is statistically 
significant (a< 0,01). This supports the hypothesis that although 
Hypaque is mainly excreted by glomerular filtration SOME tubular 
secretion also occurs resulting in clearances about 57-, higher than the 
simultaneous inulin clearance. 
4. There was no evidence to suggest tubular reabsorption of Hypaque. 
5. The inulin clearance in man can be replaced for many purposes 
by the clearance of radioactive labelled Hypaque, in critical studies the 
effect of tubular secretion can be minimised by adding unlabelled 
Hypaque to the infusion. 
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